Who owns EWTX?
Institutional ownership of Edgewise Therapeutics Inc. from Form 13F, Q2 2026
225 institutional managers reported holding Edgewise Therapeutics Inc. (EWTX) in Form 13F filings for Q2 2026, with 119,185,338 shares worth $4.8B. The largest reported holder was Orbimed Advisors LLC. Managers that filed both quarters added a net 215,836 shares (+0.2%). 38 opened new positions and 26 sold out.
- Funds holding
- 225
- Value held
- $4.8B
- New / sold out
- 38 / 26
- Net shares, same filers
- +0.2%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of EWTX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Orbimed Advisors LLC | $631M | 13.0% | 15,518,492 | Unchanged |
| Paradigm Biocapital Advisors LP | $415M | 8.6% | 10,215,455 | Added |
| Ra Capital Management, L.p. | $341M | 7.0% | 8,392,730 | Trimmed |
| BlackRock, Inc. | $268M | 5.5% | 6,606,336 | Added |
| Jupiter Topco LLC | $247M | 5.1% | 6,075,331 | First report |
| FMR LLC | $223M | 4.6% | 5,489,135 | Added |
| Novo Holdings A/S | $217M | 4.5% | 5,350,000 | Unchanged |
| Driehaus Capital Management LLC | $192M | 4.0% | 4,728,623 | Added |
| Perceptive Advisors LLC | $178M | 3.7% | 4,373,974 | Trimmed |
| Vanguard Capital Management LLC | $157M | 3.2% | 3,860,670 | Added |
| Baker Bros. Advisors LP | $150M | 3.1% | 3,701,719 | Trimmed |
| Siren, L.L.C. | $129M | 2.7% | 3,184,629 | Trimmed |
| Cormorant Asset Management, LP | $102M | 2.1% | 2,510,000 | Trimmed |
| Geode Capital Management, LLC | $88.3M | 1.8% | 2,174,051 | Added |
| Integral Health Asset Management, LLC | $81.3M | 1.7% | 2,000,000 | Added |
| Braidwell LP | $81.1M | 1.7% | 1,996,965 | Trimmed |
| Morgan Stanley | $79.2M | 1.6% | 1,948,597 | Trimmed |
| State Street Corp | $74.3M | 1.5% | 1,827,927 | Added |
| Alliancebernstein L.p. | $66.7M | 1.8% | 2,119,024 | Added |
| MPM Bioimpact LLC | $65.9M | 1.4% | 1,620,780 | Trimmed |
| Bank of America Corp | $63.3M | 1.3% | 1,558,260 | Added |
| Qube Research & Technologies Ltd | $50.9M | 1.1% | 1,252,507 | Added |
| Dimensional Fund Advisors LP | $46.3M | 1.0% | 1,139,726 | Trimmed |
| American Century Companies Inc | $45.8M | 0.9% | 1,127,078 | Trimmed |
| First Light Asset Management, LLC | $44.5M | 0.9% | 1,095,171 | Added |
Share of 13F holdings is each fund's shares as a share of the 119,185,338 EWTX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- FMR LLC Added+$182M
- Paradigm Biocapital Advisors LP Added+$116M
- Price T Rowe Associates Inc Added+$30.4M
- Tyro Capital Management LLC New+$24.9M
- Norges Bank New+$20.7M
- Adage Capital Partners GP, L.l.c. New+$18.8M
- Qube Research & Technologies Ltd Added+$17.3M
- Integral Health Asset Management, LLC Added+$16.3M
- Geode Capital Management, LLC Added+$15.6M
- Alliancebernstein L.p. Added+$12.5M
Biggest sellers in Q2 2026
- Baker Bros. Advisors LP Trimmed-$117M
- Ra Capital Management, L.p. Trimmed-$82.7M
- Siren, L.L.C. Trimmed-$50.6M
- Bellevue Group AG Sold out-$48.1M
- UBS Group AG Trimmed-$46.2M
- Soleus Capital Management, L.P. Trimmed-$40.6M
- Cormorant Asset Management, LP Trimmed-$30.5M
- Marshall Wace, LLP Trimmed-$26.1M
- Stempoint Capital LP Sold out-$18.3M
- Braidwell LP Trimmed-$14.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $631M and sold $588M; 82 added and 73 trimmed.
Schedule 13D and 13G filings on EWTX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-06FMR LLC SCHEDULE 13G filed by Edgewise Therapeutics Inc.Schedule 13G
- 2026-05-15JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Edgewise Therapeutics Inc.Schedule 13G
- 2025-02-21PERCEPTIVE ADVISORS LLC SCHEDULE 13G filed by Edgewise Therapeutics Inc.Schedule 13G
- 2025-02-14JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Edgewise Therapeutics Inc.Schedule 13G
Questions about EWTX ownership
- Who owns EWTX stock?
- 225 institutional investment managers reported EWTX positions in their Form 13F filings for Q2 2026, holding 119,185,338 shares worth $4.8B in total. Orbimed Advisors LLC reported the largest position.
- Are funds buying or selling EWTX?
- In Q2 2026, 38 managers opened new EWTX positions, 82 added, 73 trimmed and 26 sold out. Managers that filed in both quarters added a net 215,836 shares.
- How current is this EWTX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to EWTX by CUSIP. Options are left out. EWTX news and filings · EWTX insider trades · Top funds